Cost Versus Value: Earnings Calls Spotlight US Pricing Reforms
Executive Summary
Pink Sheet has scoured big pharma annual results presentations to gauge the industry's reactions and concerns around the increasingly tough US drug pricing environment and proposed changes to the Affordable Care Act under the new Trump administration.